ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs254.55 M222.71 M215.08 M281.76 M70.41 M226.01 M793.27 MRecherche et développement44.55 M36.4 M38.52 M57.23 M23.74 M44.39 M163.87 MRésultat d'exploitation99.76 M125.57 M155.31 M-408.9 M13.87 M20.18 M-219.53 MTotal des produits hors exploitation7.64 M6.16 M4.89 M7.93 M9.65 M10.01 M32.48 MCharges d'intérêts, nettes des intérêts capitalisés18.64 M18.54 M21.71 M31.84 M28.13 M25.72 M107.4 MRésultat hors exploitation, hors charges d'intérêts-11 M-12.39 M-16.82 M-23.91 M-18.48 M-15.71 M-74.92 MRevenus/dépenses exceptionnels———————Résultat avant impôts-126.76 M108.94 M135.25 M-438.58 M269.13 M-3.83 M-38.02 MPart des actionnaires dans le résultat———————Impôts9.9 M13.84 M12.66 M-29.7 M-23.36 M1.01 M-39.38 MIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées48.86 M95.1 M122.58 M-408.88 M-3.55 M-4.84 M-294.68 MActivités abandonnées-185.52 M-102 K-4 000-15 K-710.78 M-3.32 M-714.11 MRésultat net-136.66 M95 M122.58 M-408.89 M-714.33 M-8.15 M-1.01 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires-136.66 M95 M122.58 M-408.89 M-714.33 M-8.15 M-1.01 BBénéfice par action de base (BPA de base)-2.912.082.77-9.24-16.15-0.18-22.8Bénéfice par action dilué (BPA dilué)-2.892.072.77-9.24-16.15-0.18-22.8Nombre moyen d'actions de base en circulation46.84 M45.78 M44.27 M44.24 M44.62 M44.26 M—Nombre d'actions en circulation après dilution47.09 M45.93 M44.33 M44.24 M44.72 M44.26 M—EBITDA1.26 B129.65 M216.98 M107.99 M935.42 M21.66 M1.28 BEBIT1.04 B61.47 M102.49 M-66.87 M814.93 M-33.56 M816.99 MCoût des ventes355.49 M311.23 M349.8 M461.38 M-250.45 M240.84 M801.57 MAutres coûts des ventes———————Amortissements (flux de trésorerie)220.63 M68.18 M114.49 M174.86 M120.49 M55.22 M465.06 M
Teleflex Incorporated Common Stock
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer is Liam J. Kelly; Kelly is also the company's president and former chief operating officer.